Validated QPS Assays
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno-bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
Search For An Assay Here
17-Desacetyl Norgestimate (Norelgestromin)
Matrix: | Human Plasma |
Assay Range: | 0.02 - 10 ng/mL |
Sample Volume: | 0.5 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Birth Control |
Classification: | Drug Assays |
17α-Ethynylestradiol
Matrix: | Human Serum |
Assay Range: | 5.00 - 500 pg/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Birth Control |
Classification: | Drug Assays |
17α-Ethynylestradiol Levonorgestrel
Matrix: | Human Serum |
Assay Range: | 5.00 - 500 pg/mL200 - 20,000 pg/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Birth Control |
Classification: | Drug Assays |
19-Norandrosterone19-Norethiocholanolone
Matrix: | Human Urine |
Assay Range: | 0.600 - 60.0 ng/mL |
Sample Volume: | 5 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Birth Control |
Classification: | Drug Assays |
4-Butylamino-benzoic acid
Matrix: | Human Plasma |
Assay Range: | 20 - 5,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Drug Assays |
4-Phenylbutyric acid
Matrix: | Human Plasma |
Assay Range: | 0.2 - 200 µg/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
5-Fluorouracil (5-FU)
Matrix: | Human Plasma |
Assay Range: | 5 - 3,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
5-Fluorouracil (5-FU)
Capecitabine
Capecitabine
Matrix: | Human Plasma |
Assay Range: | 5.00 - 2,000 ng/mL 25.0 - 5,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTAHeparin |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
5-Fluorouracil (5-FU)
Capecitabine
Doxifluridine
Capecitabine
Doxifluridine
Matrix: | Human Plasma |
Assay Range: | 5.00 - 2,000 ng/mL 25.0 - 2,000 mg/mL 25.0 - 2,000 mg/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTAHeparin |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
6-Methoxy-2-Naphthylacetic acid (Nebumetane)
Matrix: | Human Plasma |
Assay Range: | 0.5 - 75 µg/ml |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | HPLC |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | NSAID |
Classification: | Drug Assays |
Abacavir (ABC)
Matrix: | Human Plasma |
Assay Range: | 5 - 5,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Abacavir (ABC)
Matrix: | Human Plasma |
Assay Range: | 20 - 10,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC-MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Abacavir (ABC) Lamivudine (3TC)
Matrix: | Human Plasma |
Assay Range: | 20 - 12,000 ng/mL-15 - 6,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC-MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Abeta (Aß) Total
Matrix: | Human Plasma |
Assay Range: | 100 - 8,000 pg/mL |
Sample Volume: | 0.025 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | ECL (MSD) |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Alzheimer's Disease |
Classification: | Biochemical Biomarkers |
Abeta (Aß) Total
Matrix: | Human CSF |
Assay Range: | 200 - 10,000 pg/mL |
Sample Volume: | 0.025 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -70 |
Platform: | ECL (MSD) |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Alzheimer's Disease |
Classification: | Biochemical Biomarkers |
Abiraterone
Matrix: | Human Plasma |
Assay Range: | 0.2 - 500 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | FluorideOxalate |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Abiraterone
Matrix: | Human Plasma |
Assay Range: | 0.2 - 200 ng/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Abiraterone
Matrix: | Human Plasma |
Assay Range: | 1 - 1,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Acarbose
Matrix: | Human Plasma |
Assay Range: | 3.00 - 1,000 ng/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Anti-diabetic |
Classification: | Drug Assays |
Acarbose
Matrix: | Human Urine |
Assay Range: | 3.00 - 1,000 ng/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Anti-diabetic |
Classification: | Drug Assays |
Acetaminophen
Matrix: | Human Plasma |
Assay Range: | 0.1 - 100 μg/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Analgesic |
Classification: | Drug Assays |
Acetaminophen
Matrix: | Human Plasma |
Assay Range: | 75 - 20,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Analgesic |
Classification: | Drug Assays |
Acetaminophen Dextromethorphan Dextrorphan
Matrix: | Dog Plasma |
Assay Range: | 1 - 500 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Analgesic |
Classification: | Drug Assays |
Acetaminophen Dextromethorphan Dextrorphan
Matrix: | Rat Plasma |
Assay Range: | 10 - 5,000 ng/mL1 - 500 ng/mL1 - 500 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Respiratory |
Classification: | Drug Assays |
Acetaminophen Propoxyphene
Matrix: | Human Plasma |
Assay Range: | 50 - 2,000 ng/mL 1 - 400 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Analgesic |
Classification: | Drug Assays |
Links to Relevant Documents
Testimonials
Thanks for the good news, I’m happy to see that within less than a month you will have developed and validated the assay. Good Job!
QPS CLIENT